Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma
- Tony S.K. Mok*
- , Tsai Shen Yang
- , Yee Chao
- , Cheng Hsu Wang
- , Mei Ching Liu
- , Yoon Koo Kang
- , Won Ki Kang
- , Jun Suk Kim
- , Yajie Wang
- , Thomas Leung
*此作品的通信作者
研究成果: 期刊稿件 › 文章 › 同行評審